View Article

Abstract

The International Council for Harmonization of Technical Requirements of Pharmaceuticals for human use is in charge of this quality risk management, or Q9. Every procedure and product in the pharmaceutical sector has some level of risk. According to the most recent guidance, risk is defined as the product of the likelihood that harm will occur and the seriousness of that harm. In the pharmaceutical sector, quality risk management refers to a comprehensive and ongoing process that minimizes risks to product quality in order to maintain risk, optimize benefits, enhance and sustain quality. It is a methodical procedure for identifying, managing, sharing, and reviewing risks to a pharmaceutical product's quality. QRM can be used in the pharmaceutical sector in many phases, including any biological product's lifespan, production, distribution, inspection, and evaluation of pharmaceutical items. General risk management concepts, procedures that can be effectively applied to spot possible quality problems are covered in QRM.

Keywords

QRM, Principle and Process, Tools and Application

Introduction

Every production procedure in the pharmaceutical sector has involved quality risk management, and there has historically been a risk linked to pharmaceutical products. This QRM system is a preventive or predictive1. QRM has become a mandatory regulatory requirement towards healthcare organizations2. The FDA and other regulatory bodies, is embracing the Q9 concepts. ICH Q9 QRM was created by the Expert Working Group (Quality) of the International Conference on Harmonization concerning Technical Requirements for the Registration of Pharmaceuticals for Human Use3. In general Q9 (QRM) is a whole process for maintaining and controlling potential quality issues during the development and manufacturing to ensure the high quality of drug product2 and some Q9 tools are major role play in pharmaceutical industry to more effective and consistent risk based decisions so, it is a valuable components of an effective quality system. QRM are effectively utilized in many areas of business and government including finance, insurance, occupational safety, public health, pharmacovigilance, and by agencies regulating these industries4,5.

    1. History

The late 19th century saw additional drug legislation come into effect.In the US, during the Mexican-American War of 1846–1848, many American soldiers were also dying due to disease like malaria, yellow fever, and cholera. The reason was not a slaughter scene in war time only, but also due to a lack of safety and efficacy of imported drugs. United States Import Drug Act 1848 was commissioned to test and ensure the purity and safety of imported drugs prior to border crossing7,8. But it wasn't a suitable risk management guideline until 19909. In 1999, a Task Force submitted a risk management report to the FDA Commissioner, which led to the modern discovery of risk management for pharmaceuticals and biological goods. In August 2002, the Food and Drug Administration announced a new effort called "Pharmaceutical cGMPs for the 21st Century- A Risk-based approach," which approved a proactive risk management plan that included both internal and external hazards. The final report on the FDA plan was released in September 2004.According to the paper, the FDA and the industry should jointly adopt the quality systems paradigm for regulating and managing quality7,8. The ICH's 2005 publication of the quality risk management (Q9) guideline has had a big influence on regulators and the pharmaceutical sector3. On January 20, 2023, the updated Q9(R1) guideline on quality risk management (QRM) was released by the International Council for Harmonization (ICH). The guideline became effective on July 23, 202310.

    1. Definition

Quality: The extent to which certain basic characteristics of a system, process, or product meet requirement.

Risk: Risk is a combination of the likelihood that harm will occur and the severity of that harm.

Quality risk management: A methodical  process for the control, communication, assessment, and review of  risk to the quality of the  medicine product throughout the product" life cycle is outlined in the International Conference on Harmonization’s(ICH) Q9 guidance document11,12. A quality product is largely dependent on quality risk management, which is the focus of the entire ICH-Q9 guideline. Both proactive and retroactive approaches may be used in QRM7.

Harm: Harm to health, including harm that may result from a product's losing its effectiveness, safety, quality, or availability3.

    1. Principle

According to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).

There are two primary principles of Quality risk management Which are:

  • Consumer protection should be the ultimate goal of quality risk assessment, which should be grounded in scientific knowledge such as data and research.
  • The strength of a QRM process should increase with the level of risk. The level of risk should correspond with the level of formality, paperwork, and effort6.

The QRM methodology additionally incorporates the following concepts in addition to the two already mentioned:

  • It ought to be adaptable, dynamic, and iterative.
  • The QRM process should be the foundation for improvement and ongoing development7.
    1. Scope

It offers quality risk management concepts and tool examples that can be used for various pharmaceutical quality concerns: Developmental phase, Manufacturing process, Distribution system, The inspection procedure and the procedures for submitting or reviewing drug substances, drug products, biological, and biotechnological products at every stage of their lifecycle. Biological and biotechnological products, as well as drug products, also use: Raw materials, Solvents, Excipients, Materials for packaging and labeling4.

    1. Importance of risk management

For every company that wishes to guarantee the efficacy and safety of its products, quality risk management, or QRM, is crucial. Avoiding issues is only one aspect of risk management; other aspects include process improvement and better decision-making. Organizations can take proactive steps to reduce risk by using QRM to help them see possible problems before they become serious ones. GDP, a globally accepted set of guidelines for guaranteeing the quality of medications across the supply chain, also requires quality risk management. GDP has been used more frequently in the US and other nations, although it is mainly enforced in Europe. Another advantage is that businesses can prioritize tasks based on risk level, which results in a more effective use of resources. Additionally, it fosters a transparent and trusting culture between businesses and government agencies6.

  1. Quality Risk Management Process/Model

A systematic approach to coordinating, facilitating, and enhancing science-based decision making is quality risk management9. The Quality Risk Management (QRM) approach includes several stages to guarantee that all potential risks are identified, evaluated, controlled, communicated, and re-examined. This process is crucial in maintaining high-quality standards and ensuring the safety of products and regulatory compliance13. Indeed, QRM is significant for its ability to detect and address quality concerns at the inception of product design9. The QRM model is outlined in the diagram that follows7:

Fig. 01: Quality risk management process11.

The QRM framework describes the process for identifying and resolving quality risks. Despite being primarily designed for pharmaceutical manufacturing, this model can be applied to various manufacturing systems. Manufacturers can use the QRM's general flow to make empirical decisions based on data collected. In addition to ensuring that the QRM process is well-defined, implemented, and evaluated using the readily available resources, decision-makers in the process should be in charge of organizing and working with other relevant teams and departments14.

    1. Responsibilities

The Quality risk management task are usually, but not always, handle by interdisciplinary teams4. Teams should be composed of professionals from the relevant fields (e.g. A. business development, engineering, quality unit, legal, statistics, clinical, production operations, sales and marketing, engineering, regulatory affairs, and others) in addition to those who are familiar with the quality risk management procedure. Decision makers should be able to:

  • To take the responsibility for organizing quality risk management throughout their organization's departments and functions.
  • To Ensure that sufficient resources are available and that a high-quality risk management process is established, implemented, and evaluated15.
  • To support scientifically sound risk-based decision-making, make sure that subjectivity is controlled and reduced in high-quality risk management activities5.
  • To consider all of the available scientific information and make sure that potential risk factors are systematically identified9.
    1. Initiating a Quality risk management process

The purpose of the QRM process is to reduce risk and improve quality through science-based decision-making. The steps listed above can be used to start and develop a risk management strategy.

  • The problem or risk question should be defined, along with any relevant assumptions that could indicate a risk. It should outline the risk management process's timeline, deliverables, and suitable degree of decision-making.
  • Involving all stakeholders is important, as is gathering and shared data on potential hazards, harm, and human health impact relevant to the risk assessment and deciding on the method for documenting the QRM activities2,5.
  • Selecting the right group of SMEs and a qualified facilitator and find a leader and important resources. Decide which risk management tools are appropriate to use9.

Table 1: Create a cross-functional group and select a leader example QRM team

  • Quality Manager – Leader
  • Business Developer
  • Lead Engineer
  • Operations Manager
  • Sales and Marketing Head
  • Senior Data Analyst
  • Corporate

Lawyer

  • Clinical Expert
  • Manufacturing Director

Each team member will be in charge of organizing quality risk management across the company's departments and functions6.

    1.  Risk assessment

The first step in the QRM process is risk assessment, which entails identifying potential risks as well as analyzing16 and evaluating the risks of being exposed to those risks17. A clear problem description or risk question, a suitable risk management tool, and the kinds of information that will answer the risk question are the first steps in conducting a high-quality risk assessment4. Three basic questions are frequently useful in precisely defining the risk for risk assessment purposes:2,5

  • What could probably go wrong?
  • How likely is it that something will go wrong?
  • What are the severity of the consequences?15
  • How can the failure be identified?3

Risk assessments are a useful management tool and best practice for determining, assessing, and analyzing the risks connected to a particular system or process step18.

      1. Risk identification

In quality risk management, risk identification methodically draws on a variety of information sources, including historical and theoretical data, analytical techniques, expert opinions, and stakeholder concerns, in order4,5 to identify hazards associated with a defined risk .The question, "What might go wrong?" is addressed in this step19.

      1. Risk analysis

It is the assessment of the risk connected to the hazards that have been identified. It is the qualitative or quantitative process of establishing a connection between the severity of harms and their likelihood of occurring20. In some risk management tools, the capability to detect the harm (detectability) also factors (determinants) in the analysis of risk2,11,15. This analysis is advantage when undertaken with a multi-functional team of SMEs. This assures that risks are analysed from many perspectives. Team discussion is particularly valuable so that different understandings of the risk can be surfaced9.

      1. Risk evaluation

The process of risk evaluation involves comparing the identified and analyzed risk to predetermined acceptance criteria while taking probability, severity, and detectability into account. Risk assessments take into account the quality of the evidence supporting each of the three main questions3,4. A risk evaluation's report may include a qualitative description of various risks or a quantitative assessment of risk. A numerical likelihood is used in quantitative risk expression. Another way to describe risk with qualitative descriptors like high, medium, or low. These descriptors should be determined in detail for better clarity while assigning the rating9.

High: when the adverse event or its effects are likely to be detected by the control.

Medium: when the negative event or its effects may be detected by the control.

Low: when the adverse event or its effects are unlikely to be detected by the control.

Zero: when there is no detection control3.

Table 2:   A Risk Matrix to Assess Hazards6.

Likelihood

Very likely

Likely

Unlikely

Highly unlikely

Fatality

High

High

High

Medium

Major

High

High

Medium

Medium

Minor

High

Medium

Medium

Low

Negligible

Medium

Medium

Low

Low

Risk control

Risk control involves making decisions about accepting and/or reducing risks21. Risk control aims to lower the risk to a manageable level. The importance of the risk should determine how much effort is put into risk control. Decision makers may employ a variety of techniques, such as benefit-cost analysis, to determine the ideal degree of risk control9,15.

The questions below could be the main focus of risk control.

  • Is the risk higher than what is considered reasonable?
  • What steps could be taken to decrease or eliminate risks?
  • How can we best balance benefits, risks, and resources?
  • Do new risks emerge due to the management of the identified risks?22
      1. Risk reduction

The goal of risk reduction is to lower the likelihood and severity of an event by putting in place suitable system, process, and product controls17. Implementing risk reduction strategies may enhance the importance of already-existing risks or introduce new ones into the system. Therefore, after putting a risk reduction procedure in place, it could be appropriate to revisit the risk assessment in order to find and assess any potential changes in risk15. Examine the following scenarios:

Reduce severity: Prevent failure before it has serious repercussions, reject, and remember.

Reduce probability: Analyze the batch's problems.

Increase the detection: Switch from manual to automated inspection. During clarifying events, tools are reapplied and checked to see if any new dangers emerged. The inspection process changes from being labor-intensive to being mechanical23.

      1. Risk acceptance

It is a choice to take a chance. Even the best risk management techniques may not completely remove risk for some kinds of injuries24. In such events, the QRM technique has been successfully applied, and it should be guaranteed that the risk is within an acceptable range. This acceptable limit would be determined based on a number of variables and occurrences7.

    1. Risk communication

The term "risk communication" refers to the sharing of information and details about risk management between decision-makers and other stakeholders25. The quality risk management process's output or outcome must be properly documented and shared. Interested parties may be considered stakeholders, such as industry and the patient, industry and regulators, within a company, industry or regulatory authority, etc.5,9

    1. Risk review

It is necessary to examine the output and outcomes of the risk management process in order to incorporate fresh knowledge and information. Events that could affect the initial quality risk management decision should continue to be handled through the quality risk management process once it has been started. Risk acceptance choices may be modified as part of a risk review11.

  1. Risk Management Tools

A scientific and practical approach to decision-making is supported by quality risk management tools, which offer transparent, reproducible, and recorded ways to complete the process26.

Table 3: Risk management tools2,11,7,4,27,20

Risk management tool

Description/attributes

Potential applications

Primary Tools

  1. Flow charts
  2. Process mapping
  3. Diagram analysis
  4. Check sheets
  5. Cause or effect diagrams
  • It is a basic method that is frequently employed to collect and arrange information, coordinate processes for quality risk management, and support decision-makers.
  • collection of patterns, observations, or other factual information to back up a range of simpler deviations, issues, mistakes, or other incidents.

Risk ranking and filtering

  • A system for separating and evaluating risks.
  • Usually include weighing factors and risk ratings, as well as evaluating a variety of quantitative and qualitative criteria for each risk.

 

  • Select operating areas and sites for audit or assessment according to industry or audit priority.
  • Helpful during situations where it is challenging to compare risks and underlying effects with a single tool due to their diversity.

Secondary Tools

 

 

Hazard operability analysis (HAZOP)

  • It is predicated on the idea that deviations from the design or operating intentions are what lead to risk incidents.
  • This method is employed to detect possible deviation from standard usage or design objectives.
  • Useful for facilities, machinery, and production processes for drug substances and drug (medicinal) products.
  • Assessing the risks to process safety.

Hazards analysis and critical control points (HACCP)

  • Identifying and putting into place process controls to consistently and successfully stop dangerous events.
  • Finding solutions to stop risks from occurring or increasing and focusing on prevention control over detectability is beneficial.
  • A detailed understanding of the procedure and the CCPs should be established prior to starting the review. Tools guarantee that CPPs are fulfilled.
  • More appropriate for proactive rather than reactive practice.
  • A better precursor for process verification.
  • Evaluation of the efficacy and reliability of the essential process parameter in any process.

Preliminary hazard analysis (PHA)

Based on using past experience or understanding of a hazard or failing to recognize future risks, dangerous situations, and occurrences that could be harmful, as well as estimating the likelihood that they will occur for a certain activity, facility, product, or system.

  • Evaluating current systems or ranking risks in situations where circumstances preclude the application of a more involved method.
  • Projects with limited understanding of the design or manufacturing process benefit from PHA. It will serve as a precursor to larger research projects in the future.

Failure modes effects analysis (FMEA)

  • FMEA allows for the estimation of various process failure modes and their potential impact on results and/or product performance.
  • Analyze facilities and equipment; find high-risk phases or crucial parameters in a manufacturing process.

Failure Mode, Effects and Criticality Analysis (FMECA)

  • It is an extension of FMEA that charts the likelihood of failure modes versus the seriousness of the effects using a criticality analysis.
  • It indicates the areas in which further steps may be necessary to reduce risk.

CONCLUSION

Four main components make up the systematic process of quality risk management: risk assessment, risk control, risk communication, and review of risks to the drug product's quality throughout its lifecycle. The process of risk management also heavily relies on the choice of team and approach. In addition to ensuring that risks are appropriately managed, QRM assists in the pharmaceutical industry in making consistent and traceable decisions that will lower risk through the consistent use of tools and methods. As a result, risk management in the pharmaceutical industry leads to increased safety, improved quality, lower development time, and less waste. Internal and external requirements are met by the efficiency of risk management, and regulatory audits and inspections are conducted in a more methodical manner. The organization can achieve its goals with the help of QRM.

REFERENCES

  1. Chaudhary M, Priya. Hazard Analysis and Critical Control Points as a Quality Risk Management Tool in the Pharmaceutical Industry: A Systematic Review. J Drug Deliv Ther. 2021;11(5-S):167-75.
  2. Vijayakumar Reddy V, Gupta NV, Raghunandan HV, Kashyap UN. Quality Risk Management in Pharmaceutical Industry: A Review. Int J PharmTech Res. 2014;6(3):908-14.
  3. Lotlikar MV. Quality Risk Management (QRM): A Review. J Drug Deliv Ther. 2013;3(2):149-54.
  4. Khan AS, Khan F, Rao N. Quality Risk Management in Pharmaceutical Industries. Int J Res Pharm Chem. 2020;10(2):215-23.
  5. International Council for Harmonisation (ICH). ICH guideline Q9 (R1) on quality risk management Step 5. Geneva: ICH; 2023.
  6. SafetyCulture. Quality Risk Management [Internet]. Sydney: SafetyCulture; [cited 2025 Mar 22]. Available from: https://safetyculture.com/topics/quality-risk-management/
  7. Sharma A, Jayaprakash RM, Bora R, Chandra A. Impact of Quality Risk Management Process in Pharmaceutical Industry to Curtail the Non-Conformity. Int J Pharm Qual Assur. 2020;11(1):179-85.
  8. Pharmaceutical Online. Quality risk management: A brief history of risk management in the regulation of medicinal products [Internet]. [cited 2025 Mar 23]. Available from: https://www.pharmaceuticalonline.com/doc/quality-risk-management-a-brief-history-of-risk-management-in-the-regulation-of-medicinal-products-0001
  9. Kumar SJ. Quality Risk Management – CAPA to Prevent Potential Quality Issues. Asian J Pharm Res Dev. 2017;5(1):1-11.
  10. Regulatory Affairs Professionals Society (RAPS). ICH adopts Q9 guidelines on quality risk management [Internet]. 2023 Jan [cited 2025 Mar 24]. Available from: https://www.raps.org/News-and-Articles/News-Articles/2023/1/ICH-adopts-Q9-guidelines-on-quality-risk-management
  11. Sivadasu S, Gangadharappa HV, Kiran HC, Jose A. Quality Risk Management: A Review. Int J Pharm Sci Rev Res. 2017;44(1):142-8.
  12. SlideShare. Quality Risk Management [Internet]. [cited 2025 Mar 26]. Available from: https://www.slideshare.net/slideshow/quality-risk-management-73518263/73518263
  13. 6Sigma.us. Quality Risk Management (QRM) [Internet]. [cited 2025 Mar 26]. Available from: https://www.6sigma.us/six-sigma-in-focus/quality-risk-management-qrm/
  14. TRDSF. Quality Risk Management [Internet]. [cited 2025 Mar 28]. Available from: https://trdsf.com/blogs/news/quality-risk-management
  15. U.S. Food and Drug Administration. Q9(R1) Quality Risk Management: Guidance for Industry. Silver Spring (MD): U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER); 2023. (ICH-Quality). Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q9r1-quality-risk-management
  16. Mire-Sluis A, Ramnarine E, Siemiatkoski J, Weese D, Swann P, O’Keeffe R, Kutza J, Edwards J, McLeod L. Practical applications of quality risk management. BioProcess Int. 2010;8(3):20-32.
  17. Ismael OA, Ahmed MI. Using Quality Risk Management in Pharmaceutical Industries: A Case Study. ResGate. 2020;21(178):106-13.
  18. Compliance Team LLC. What is Quality Risk Management? [Internet]. [cited 2025 Mar 30]. Available from: https://www.complianceteamllc.com/what-is-quality-risk-management/
  19. GMP Insiders Expert Team. Quality Risk Management in the Pharmaceutical Industry [Internet]. GMP Insiders; 2024 Jan 2 [cited 2025 Apr 1]. Available from: https://gmpinsiders.com/quality-risk-management-in-pharmaceutical-industry/
  20. Bakshi I, Puri K, Kaur S. Applications of quality risk management tool in pharmaceutical industry: A comprehensive review. SPER Publications. 2018;10(4):148-52.
  21. World Health Organization. WHO Expert Committee on Specifications for Pharmaceutical Preparations: Forty-Seventh Report. Geneva: World Health Organization; 2013.p. 202. Available from: https://apo.who.int/publications/i/item/WHO_TRS_981_eng
  22. Missouri Information Technology Advisory Board Project Management Committee Risk Subcommittee. Risk Management: Guidelines and Best Practices. Missouri; 2003.
  23. Mahony AO. Quality Risk Management: The Pharmaceutical Experience. November 2011.
  24. Sivadasu S, Gangadharappa HV, Kiran HC, Jose A. Quality risk management: A review. Int J Pharm Sci Rev Res. 2017;44(1):142-8.
  25. Nauman M, Bano R. Implementation of quality risk management (QRM) in pharmaceutical manufacturing industry. IOSR J Pharm Biol Sci. 2014;9(1):95-101.
  26. Dahiya S, Khar RK, Chhikara A. Opportunities, challenges and benefits of using HACCP as a quality risk management tool in the pharmaceutical industry. Qual Assur J. 2009;12(2):95–104.
  27. Stamatis DH. Failure Mode and Effect Analysis: FMEA from Theory to Execution. 2nd ed. Milwaukee (WI): ASQ Quality Press; 2003.

Reference

  1. Chaudhary M, Priya. Hazard Analysis and Critical Control Points as a Quality Risk Management Tool in the Pharmaceutical Industry: A Systematic Review. J Drug Deliv Ther. 2021;11(5-S):167-75.
  2. Vijayakumar Reddy V, Gupta NV, Raghunandan HV, Kashyap UN. Quality Risk Management in Pharmaceutical Industry: A Review. Int J PharmTech Res. 2014;6(3):908-14.
  3. Lotlikar MV. Quality Risk Management (QRM): A Review. J Drug Deliv Ther. 2013;3(2):149-54.
  4. Khan AS, Khan F, Rao N. Quality Risk Management in Pharmaceutical Industries. Int J Res Pharm Chem. 2020;10(2):215-23.
  5. International Council for Harmonisation (ICH). ICH guideline Q9 (R1) on quality risk management Step 5. Geneva: ICH; 2023.
  6. SafetyCulture. Quality Risk Management [Internet]. Sydney: SafetyCulture; [cited 2025 Mar 22]. Available from: https://safetyculture.com/topics/quality-risk-management/
  7. Sharma A, Jayaprakash RM, Bora R, Chandra A. Impact of Quality Risk Management Process in Pharmaceutical Industry to Curtail the Non-Conformity. Int J Pharm Qual Assur. 2020;11(1):179-85.
  8. Pharmaceutical Online. Quality risk management: A brief history of risk management in the regulation of medicinal products [Internet]. [cited 2025 Mar 23]. Available from: https://www.pharmaceuticalonline.com/doc/quality-risk-management-a-brief-history-of-risk-management-in-the-regulation-of-medicinal-products-0001
  9. Kumar SJ. Quality Risk Management – CAPA to Prevent Potential Quality Issues. Asian J Pharm Res Dev. 2017;5(1):1-11.
  10. Regulatory Affairs Professionals Society (RAPS). ICH adopts Q9 guidelines on quality risk management [Internet]. 2023 Jan [cited 2025 Mar 24]. Available from: https://www.raps.org/News-and-Articles/News-Articles/2023/1/ICH-adopts-Q9-guidelines-on-quality-risk-management
  11. Sivadasu S, Gangadharappa HV, Kiran HC, Jose A. Quality Risk Management: A Review. Int J Pharm Sci Rev Res. 2017;44(1):142-8.
  12. SlideShare. Quality Risk Management [Internet]. [cited 2025 Mar 26]. Available from: https://www.slideshare.net/slideshow/quality-risk-management-73518263/73518263
  13. 6Sigma.us. Quality Risk Management (QRM) [Internet]. [cited 2025 Mar 26]. Available from: https://www.6sigma.us/six-sigma-in-focus/quality-risk-management-qrm/
  14. TRDSF. Quality Risk Management [Internet]. [cited 2025 Mar 28]. Available from: https://trdsf.com/blogs/news/quality-risk-management
  15. U.S. Food and Drug Administration. Q9(R1) Quality Risk Management: Guidance for Industry. Silver Spring (MD): U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER); 2023. (ICH-Quality). Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q9r1-quality-risk-management
  16. Mire-Sluis A, Ramnarine E, Siemiatkoski J, Weese D, Swann P, O’Keeffe R, Kutza J, Edwards J, McLeod L. Practical applications of quality risk management. BioProcess Int. 2010;8(3):20-32.
  17. Ismael OA, Ahmed MI. Using Quality Risk Management in Pharmaceutical Industries: A Case Study. ResGate. 2020;21(178):106-13.
  18. Compliance Team LLC. What is Quality Risk Management? [Internet]. [cited 2025 Mar 30]. Available from: https://www.complianceteamllc.com/what-is-quality-risk-management/
  19. GMP Insiders Expert Team. Quality Risk Management in the Pharmaceutical Industry [Internet]. GMP Insiders; 2024 Jan 2 [cited 2025 Apr 1]. Available from: https://gmpinsiders.com/quality-risk-management-in-pharmaceutical-industry/
  20. Bakshi I, Puri K, Kaur S. Applications of quality risk management tool in pharmaceutical industry: A comprehensive review. SPER Publications. 2018;10(4):148-52.
  21. World Health Organization. WHO Expert Committee on Specifications for Pharmaceutical Preparations: Forty-Seventh Report. Geneva: World Health Organization; 2013.p. 202. Available from: https://apo.who.int/publications/i/item/WHO_TRS_981_eng
  22. Missouri Information Technology Advisory Board Project Management Committee Risk Subcommittee. Risk Management: Guidelines and Best Practices. Missouri; 2003.
  23. Mahony AO. Quality Risk Management: The Pharmaceutical Experience. November 2011.
  24. Sivadasu S, Gangadharappa HV, Kiran HC, Jose A. Quality risk management: A review. Int J Pharm Sci Rev Res. 2017;44(1):142-8.
  25. Nauman M, Bano R. Implementation of quality risk management (QRM) in pharmaceutical manufacturing industry. IOSR J Pharm Biol Sci. 2014;9(1):95-101.
  26. Dahiya S, Khar RK, Chhikara A. Opportunities, challenges and benefits of using HACCP as a quality risk management tool in the pharmaceutical industry. Qual Assur J. 2009;12(2):95–104.
  27. Stamatis DH. Failure Mode and Effect Analysis: FMEA from Theory to Execution. 2nd ed. Milwaukee (WI): ASQ Quality Press; 2003.

Photo
Dr. Gurmeet Chhabra
Corresponding author

Department of Quality Assurance, Indore Institute of Pharmacy, Pithampur road, Opposite to IIM, Rau, Indore, Madhya Pradesh, Pincode – 453331, India.

Photo
Gourav Kushwah
Co-author

Department of Quality Assurance, Indore Institute of Pharmacy, Pithampur road, Opposite to IIM, Rau, Indore, Madhya Pradesh, Pincode – 453331, India.

Photo
Dr. Nimita Manocha
Co-author

Department of Quality Assurance, Indore Institute of Pharmacy, Pithampur road, Opposite to IIM, Rau, Indore, Madhya Pradesh, Pincode – 453331, India.

Photo
Gaurav Sarsodia
Co-author

Department of Quality Assurance, Indore Institute of Pharmacy, Pithampur road, Opposite to IIM, Rau, Indore, Madhya Pradesh, Pincode – 453331, India.

Gourav Kushwah, Dr. Gurmeet Chhabra*, Dr. Nimita Manocha, Gaurav Sarsodia, Quality Risk Management: A Current International Pharmaceutical Industry Practice to Optimize the Product Quality, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 7, 96-106. https://doi.org/10.5281/zenodo.15782537

More related articles
AI in Pharmacovigilance: Transforming Drug Safety ...
Gauri Chaudhari, Vaishali Rawal, Sakshi Dawange, Vrushali Ghuge, ...
Lavender Essence: Unveiling Its Potential Role in ...
Ankita B Shinde, Aryan K Bhadane , L. K. Wagh, A.B. Darekar, ...
UV Spectrophotometric Method Development and Valid...
Dipannita Naskar, Dr. Subhabrota Majumdar, Banhishikha Kar, ...
Review on Green Pharmacy Practice ...
N. B. Patil Thorat, A. S. Kulkarni, S. P. Patil, T. G. Dhobale, A. R. Satale, ...
A Comprehensive Review on Herbal Shampoo...
Shivani Tekale , Avinash Jiddewar , ...
Micro Engineering To Create Bio Mimic Living Systems With Organ-On-A-Chip ...
Sabafarin Hasin Shaikh, Mohammad Sufiyan, Sagar Patki, Rohit Karad, Niket Pradhan, Sushmita Chavan,...
Related Articles
Extraction Isolation Phytochemical Screening and Analysis of Madhunashini (Gymne...
Tejal Dingore , Dev Gaikwad , Swati Wakchoure, Akash Nalawade, Leena Gharat, Kamini Ghavat, ...
Activated charcoal: Exploring potential against Psoriasis...
Bhavana S. Daund, Swati M. Desale, Jyotiram G. Nannavare, Riya R. Navale, Deepak B. Somavanshi, ...
Natural Pigment-Based Herbal Lipsticks: Formulation, Physicochemical Evaluation,...
Dr. C. C. Patil, Arjun Uppar, Mohammadi Begam, Mohammad Kaif R Jamadar, Prakash Suryawanshi, Priyank...
AI in Pharmacovigilance: Transforming Drug Safety Through Digital Innovation...
Gauri Chaudhari, Vaishali Rawal, Sakshi Dawange, Vrushali Ghuge, ...
More related articles
AI in Pharmacovigilance: Transforming Drug Safety Through Digital Innovation...
Gauri Chaudhari, Vaishali Rawal, Sakshi Dawange, Vrushali Ghuge, ...
Lavender Essence: Unveiling Its Potential Role in Cardiovascular Health Explorin...
Ankita B Shinde, Aryan K Bhadane , L. K. Wagh, A.B. Darekar, ...
UV Spectrophotometric Method Development and Validation for the Determination of...
Dipannita Naskar, Dr. Subhabrota Majumdar, Banhishikha Kar, ...
AI in Pharmacovigilance: Transforming Drug Safety Through Digital Innovation...
Gauri Chaudhari, Vaishali Rawal, Sakshi Dawange, Vrushali Ghuge, ...
Lavender Essence: Unveiling Its Potential Role in Cardiovascular Health Explorin...
Ankita B Shinde, Aryan K Bhadane , L. K. Wagh, A.B. Darekar, ...
UV Spectrophotometric Method Development and Validation for the Determination of...
Dipannita Naskar, Dr. Subhabrota Majumdar, Banhishikha Kar, ...